Benzinga | Jan 19, 2022 06:17AM EST

Wells Fargo Upgrades Tandem Diabetes Care to Overweight, Announces $160 Price Target

Wells Fargo analyst Lawrence Biegelsen upgrades Tandem Diabetes Care (NASDAQ:TNDM) from Equal-Weight to Overweight and announces $160 price target.